Gwen's research in the lab involves understanding NK cell interactions with myeloid cells in the hypoxic tumor microenvironment of solid tumors and developing Tri-specific Killer Engager (TriKE) as a new NK cell-targeted therapy for advanced prostate cancer. Outside the lab, she enjoys dancing, bouldering and creating fun Instagram reels.